Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma.

Ramchandren R, Advani RH, Ansell SM, Bartlett NL, Chen R, Connors JM, Feldman T, Forero-Torres A, Friedberg JW, Gopal AK, Gordon LI, Kuruvilla J, Savage KJ, Younes A, Engley G, Manley TJ, Fenton K, Straus DJ.

Clin Cancer Res. 2019 Mar 15;25(6):1718-1726. doi: 10.1158/1078-0432.CCR-18-2435. Epub 2019 Jan 7.

PMID:
30617130
2.

Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment.

Zhao B, Chen R, O'Connor OA, Gopal AK, Ramchandren R, Goy A, Matous JV, Fasanmade AA, Manley TJ, Han TH.

Br J Clin Pharmacol. 2016 Sep;82(3):696-705. doi: 10.1111/bcp.12988. Epub 2016 May 29.

3.

Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline.

Jaspan HB, Brothers AW, Campbell AJ, McGuire JK, Browd SR, Manley TJ, Pak D, Weissman SJ.

Pediatr Infect Dis J. 2010 Apr;29(4):379-81. doi: 10.1097/INF.0b013e3181c806d8.

4.

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Gutman JA, Turtle CJ, Manley TJ, Heimfeld S, Bernstein ID, Riddell SR, Delaney C.

Blood. 2010 Jan 28;115(4):757-65. doi: 10.1182/blood-2009-07-228999. Epub 2009 Oct 12.

5.

Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.

Jagannathan P, Osborne CM, Royce C, Manion MM, Tilton JC, Li L, Fischer S, Hallahan CW, Metcalf JA, McLaughlin M, Pipeling M, McDyer JF, Manley TJ, Meier JL, Altman JD, Hertel L, Davey RT Jr, Connors M, Migueles SA.

J Virol. 2009 Mar;83(6):2728-42. doi: 10.1128/JVI.02128-08. Epub 2009 Jan 7.

6.

Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.

Woolfrey AE, Malhotra U, Harrington RD, McNevin J, Manley TJ, Riddell SR, Coombs RW, Appelbaum FR, Corey L, Storb R.

Blood. 2008 Oct 15;112(8):3484-7. doi: 10.1182/blood-2008-05-157511. Epub 2008 Aug 12.

7.
8.

Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection.

Manley TJ, Luy L, Jones T, Boeckh M, Mutimer H, Riddell SR.

Blood. 2004 Aug 15;104(4):1075-82. Epub 2004 Mar 23.

PMID:
15039282
9.

Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.

Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, Spies T.

J Immunol. 2003 Apr 15;170(8):4196-200.

10.

Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?

Awaya N, Baerlocher GM, Manley TJ, Sanders JE, Mielcarek M, Torok-Storb B, Lansdorp PM.

Biol Blood Marrow Transplant. 2002;8(11):597-600. Review.

PMID:
12463478
11.

Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy.

Manley TJ, Chusid MJ, Rand SD, Wells D, Margolis DA.

Pediatr Infect Dis J. 1998 May;17(5):433-4. No abstract available.

PMID:
9613664
12.

Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.

Robertson MJ, Manley TJ, Pichert G, Cameron C, Cochran KJ, Levine H, Ritz J.

Leuk Lymphoma. 1995 Mar;17(1-2):51-61.

PMID:
7539660
13.

Costimulatory signals are required for optimal proliferation of human natural killer cells.

Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J.

J Immunol. 1993 Mar 1;150(5):1705-14.

PMID:
7679691
14.

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.

Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J.

J Exp Med. 1992 Mar 1;175(3):779-88.

15.

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.

Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.

Eur J Immunol. 1992 Jan;22(1):1-6.

PMID:
1370410
16.

Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.

Baume DM, Caligiuri MA, Manley TJ, Daley JF, Ritz J.

Cell Immunol. 1990 Dec;131(2):352-65.

PMID:
2122925
17.

Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.

Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J.

J Immunol. 1990 Nov 15;145(10):3194-201.

PMID:
1700001
18.

Supplemental Content

Loading ...
Support Center